Ligand Holds Investor and Analyst Day; Provides Update on Portfolio Progress and Recent Transactions; Introduces 2024 Guidance
12.12.2023 - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) hosted an Investor and Analyst Day in New York City earlier today. CEO Todd Davis and other members of Ligand’s senior management team provided an overview of the company’s business model and ... Seite 1
United States New York Todd Davis Verona Pharma Ligand Pharmaceuticals Incorporated Ligand Holds Investor
Source: wallstreet-online.de